Whitehawk Therapeutics (WHWK) Net Cash Flow Growth (3y) (2013 - 2026)
Whitehawk Therapeutics (WHWK) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - | 17.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.64% |
| Dec 31, 2025 | 84.41% |
| Sep 30, 2025 | -105.32% |
| Jun 30, 2025 | -95.56% |
| Mar 31, 2025 | 131.39% |
| Dec 31, 2024 | 46.78% |
| Sep 30, 2024 | -27.46% |
| Jun 30, 2024 | -57.16% |
| Mar 31, 2024 | -41.89% |
| Dec 31, 2023 | -21.78% |
| Sep 30, 2023 | 26.84% |
| Jun 30, 2023 | 49.10% |
| Mar 31, 2023 | -8.07% |
| Dec 31, 2022 | -170.03% |
| Sep 30, 2022 | 75.14% |
| Jun 30, 2022 | -28.02% |
| Mar 31, 2022 | -27.70% |
| Dec 31, 2021 | -25.99% |
| Sep 30, 2021 | 1,739.33% |
| Jun 30, 2021 | -27.22% |